Different effects of bariatric surgical procedures on dyslipidemia: a registry-based analysis

Background: The scale and variables linked to bariatric surgery's effect on dyslipidemia have not been conclusive. Objective: To compare the effect of Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and adjustable gastric banding (LAGB) on dyslipidemia Setting: National bariatric surgery registry. Methods: Plasma lipids and associated variables were compared at baseline and 1 year (12 +/- 4 mo) after surgery for registry patients with dyslipidemia enrolled from June 2013 to August 2014. Results: The greatest mean total-cholesterol (TC) reduction was observed post-RYGB, 226.7 +/- 26.4 to 181.3 +/- 30.9 mg/dL (19.9%, n = 208), followed by post-SG, 227.9 +/- 24.4 to 206.7 +/- 34.2 mg/dL (8.9%, n = 1515; P < .001). Normal TC levels of below 200 mg/dL were achieved by 76% post-RYGB patients compared with 43.5% post-SG patients (odds ratio [OR] = 6.24, 95% confidence interval [CI]: 3.69-10.53) and 25.6% post-LABG patients (OR = 9.66, 95% CI: 4.11-22.67; P < .01). Although equivalent patterns were observed for low-density-lipoprotein cholesterol (LDL), the levels of high-density-lipoprotein cholesterol (HDL) were most improved post-SG, reaching normal levels in 58.1% of SG male patients versus 39.5% of RYGB male patients (OR = 1.56, 95% CI: 1.04-2.35), (P = .02). The lowering of triglyceride levels by approximately 75% was comparable after SG and RYGB procedures. The type of surgery was the strongest independent predictor for all lipid level improvements or remissions. Male sex was an independent predictor for LDL normalization only (OR = 1.88, 95% CI: 1.24-2.85). Excess weight loss offered no meaningful prediction for lipid improvement (OR = 1.01-1.03). Conclusion: Particular types of bariatric surgeries had different effects on dyslipidemia, independent of weight loss. Overall, the RYGB achieved the biggest reduction in plasma lipids (TC and LDL), although SG did affect HDL. Our results could aid in the decision-making process regarding the most appropriate procedure for patients with dyslipidemia. (C) 2017 American Society for Metabolic and Bariatric Surgery. All rights reserved.